Sivers Semiconductors: MSCI-Induced Rally Masks 15% Dilution Hurdle at June AGM

Sivers stock surges 11.69% on MSCI inclusion, but delayed Q1 report, restated losses, insider trading probe, and potential equity dilution loom ahead of May 29 shareholder vote.

Sivers Semiconductors is charging into one of its most consequential months in recent history, with a technical boost from index rebalancing colliding head-on with a shareholder vote that could substantially dilute existing equity. The stock has already priced in some of the optimism, surging 11.69 percent to 65.95 SEK on Friday, briefly touching a fresh 52-week high of 67.55 SEK. That rally, however, masks a series of governance and capital structure decisions that will test investor appetite for management’s growth ambitions.

The immediate catalyst is a double event on May 29. After markets close, Sivers will join the MSCI Sweden Small Cap Index, forcing passive funds to adjust their holdings. On the same day, the company will finally publish its delayed quarterly report — a release that was initially scheduled for May 20 but pushed back due to a sweeping restatement of its financial statements. The restatement, which aligns Sivers’ group accounts with US PCAOB standards in preparation for a potential secondary listing on Nasdaq New York, has already rewound the clock on previously reported numbers.

The revised figures for 2024 show revenue of 219.2 million SEK and a net loss of 183.9 million SEK — roughly 68 million SEK deeper than originally stated. For 2025, revenue climbed to 306.6 million SEK, but the operating loss widened to 177.8 million SEK, compared to an earlier 141.3 million SEK. The bottom-line net loss landed at 222.6 million SEK, 36 million SEK worse than the old version, while equity shrank to 949.8 million SEK from around 1.08 billion SEK. Sivers attributed the changes to revenue reclassification between periods, inventory adjustments, changes in assumptions for share-based compensation, and impairments of capitalised development costs.

The accounting overhaul comes against a backdrop of legal noise. Sweden’s Economic Crime Authority is investigating possible insider trading linked to the Nasdaq listing announcement. Roughly 48 hours before the official press release in April, an anonymous account with significant reach posted details on X, triggering unusual share price movements. Prosecutors are now examining whether this breached EU market abuse regulations.

Shareholder pressure is also mounting from another direction. Achilles Capital, the largest individual investor, is tied to DDM Finance, which defaulted on its bonds and is now in restructuring. DDM aims to sell off credit portfolios and tech and life sciences holdings worth between 30 and 50 million euros — and whether Sivers’ stake is part of that package remains open. On the short side, Voleon Capital holds a 1.86 percent short position, with Two Sigma at 1.78 percent.

Operationally, the company continues to secure defence contracts. It recently obtained a one-year renewal for the second year of the EW-STAR project, valued at 6.6 million dollars, in partnership with BAE Systems, MIT Lincoln Laboratory, and Columbia University. Management has also committed to a 180-day lock-up on new share issuance, with the CEO and CFO facing a 90-day selling restriction. The path to operating cash flow breakeven, Sivers says, requires an annualised revenue run-rate of 50 to 55 million dollars, and a long-term gross margin target above 50 percent.

All of this sets the stage for the annual general meeting on June 15 in Stockholm, where the board is up for reconfiguration. The nomination committee has proposed Joakim Nideborn and Helena Svancar as new directors, with Bami Bastani returning as chairman, Todd Thomson and Karin Raj also seeking re-election, and Nideborn earmarked as vice-chairman. Tomas Duffy, Erik Fällström, and Keith Halsey are stepping down. The new lineup is designed to bring greater capital markets experience and international technology expertise to a company eyeing a US listing.

But the real tension at the AGM will be over two capital measures. The first is a long-term incentive programme covering up to 7 million stock options, representing a dilution of roughly 2 percent on a fully diluted basis, backed by the issuance of 7 million class C shares. The second is a far larger general authorisation for the board to issue shares, warrants, and convertible bonds equivalent to up to 53,844,956 common shares — a potential dilution of around 15 percent of the current share count. The stated purposes range from funding organic growth and M&A to onboarding new strategic shareholders and enabling a dual listing on Nasdaq New York.

For existing shareholders, the June 15 vote is the moment of truth. They will decide not only who sits on the board but how much financial flexibility — and dilution risk — they are willing to grant the company as it chases its photonics and mmWave dreams in AI data centres, satellite communications, and advanced sensing. The MSCI-driven rally may have lifted the stock, but it also raises the stakes: the same investors who are cheering the index inclusion could be the ones funding the next growth phase out of their own equity stake.